Synthesis and pharmacological evaluation of new flosulide analogues, synthesized from natural safrole

Bioorganic and Medicinal Chemistry Letters

Volumn 8, Issue 2, 1998, Pages 183-188

  Lages, Adriana S ^a   Silva, Kelli C M ^a   Miranda, Ana L P ^a   Fraga, Carlos A M ^a   Barreiro, Eliezer J ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CARRAGEENAN; CYCLOOXYGENASE 2; FLOSULIDE; FLOSULIDE DERIVATIVE; INDOMETACIN; NIMESULIDE; NONSTEROID ANTIINFLAMMATORY AGENT; SAFROLE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CHEMICAL MODIFICATION; CONTROLLED STUDY; DRUG SYNTHESIS; FEMALE; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PAW EDEMA; PLEURISY; RAT; REACTION ANALYSIS;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CYCLOOXYGENASE INHIBITORS; DISEASE MODELS, ANIMAL; DRUG EVALUATION; EDEMA; FEMALE; INDANS; MALE; PLEURISY; RATS; SAFROLE;

ANIMALIA; STAPHYLOCOCCUS PHAGE 3A;

EID: 0032548459     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(97)10216-5     Document Type: Article

References (32)

1. 1. Wallace, J. L.; Cirino, G. Trends Pharm. Sci. 1994, 15, 190.
2. 2. Masferrer, J. L.; Zweifel, B. S.; Seibert, K.; Needleman, P. J. Clin. Invest., 1990, 86, 1375.
3. 3. Cronstein, B. N.; Weissmann, G. Ann. Rev. Pharmacol. Toxicol. 1995, 35, 449.
4. 4. Masferrer, J. L.; Seibert, K.; Zweifel, B.; Needleman, P. Proc. Natl. Acad. Sci. U.S.A. 1992, 89, 3917.
5. 5. Klein, T.; Nüsing, R. M.; Wiesenberg-Boettcher, L; Ullrich, V. Biochem. Pharmacol. 1996, 51, 285.
6. 6. Allison, M. C.; Howatson, A. G.; Torrance, C. J.; Lee, F. D.; Russell, R. I. N. Engl. J. Med 1992, 327, 749.
7. 7. Schlondorff, D. Kidney Int. 1993, 44, 643.
8. 8. Masferrer, J. L.; Zweifel, B. S.; Manning, P. T.; Hauser, S. D.; Leahy, K. M.; Smith, W. G.; Isakson, P. C.; Seibert, K. Proc. Natl. Acad. Sci. 1994, 91, 3228.
9. 9. Smith, W. L.; Meade, E. A.; DeWitt, D. L. Ann. N.Y. Acad. Sci. 1994, 714, 136.
10. 10. Chan, C.; Boyce, S.; Brideau, C.; Ford-Hutchinson, A. W.; Gordon, R.; Guay, D.; Hill, R. G. Li C.; Mancini, J.; Penneton, M.; Prasit, P.; Rasori, R.; Riendeau, D.; Roy, P.; Tagari, P.; Vickers, P.; Wong, E.; Rodger, I. W. J. Pharm. Exp. Ther. 1995, 274, 1531.
11. 11. (a) Reitz, D. B.; Li, J. J.; Norton, M. B.; Reinhard, E. J.; Collins, J. T.; Anderson, G. D.; Gregory, S. A.; Koboldt, C. M.; Perkins, W. E.; Seibert, K.; Isakson, P. C. J. Med. Chem. 1994, 37, 3878.
12. (b) Li, C.; Black, W. C.; Chan, C.; Ford-Hutchinson, A. W.; Gauthier, J.; Gordon, R.; Guay, D.; Kargman, S.; Lau, C. K.; Mancini, J.; Ouimet, N.; Roy, P.; Vickers, P.; Wong, E.; Young, R. N.; Zamboni, R.; Prasit, P. J. Med. Chem. 1995, 38, 4897.
13. (c) Huang, H., Li, J. J., Garland, D. J., Chamberlian, T. S., Reinhard, E. J., Manning, R. E., Seibert, K., Kodoldt, C. M., Gregory, S. A., Anderson, G. D., Veenhuizen, A. W., Zhang, Y., Perkins, W. E., Burton, E. G., Cogburn, J. N., Isakson, P. C.; Reitz, D. B. J. Med. Chem. 1996, 39, 253.
14. (d) Li, J. J., Norton, M. B., Reinhard. E. J., Anderson, G. D., Gregory, S. A., Isakson, P. C., Koboldt, C. M., Masferrer, J. L., Perkins, W. E., Seibert, K., Zhang, Y., Zweifel, B. S. and Reitz, D. B. J. Med. Chem. 1996, 39, 1846.
15. (e) Rabasseda, X. Drugs of Today 1996, 32 (Suppl), 1.
16. 12. (a) Barreiro, E. J.; Costa, P. R. R.; Barros, P. R. V. R.; Queiroz, W. M. J. Chem. Res. (M) 1982, 1142.
17. (b) Fraga, C. A. M. and Barreiro, E. J. J. Heterocycl. Chem. 1992, 29, 1667.
18. (c) Barreiro, E. J. and Lima, M. E. F. J. Pharmacol. Sci. 1992, 81, 1219.
19. (d) Silva, E. F.; Barreiro, E. J. J. Braz. Chem. Soc. 1993, 4, 40.
20. (e) Cabral, L. M.; Barreiro, E. J. J. Heterocycl Chem. 1995, 32, 959.
21. (f) Cabral, L. M.; Costa, P. R. R.; Vasconcellos, M. L. A. A.; Barreiro, E. J.; Castro, R. N. Synth. Comm. 1996, 26, 3671.
22. 13. Abstract from M.Sc.Thesis of A. S. Lages, Institute de Quimica; Universidade Federal do Rio de Janeiro, 1996.
23. 14. Wiesenberg-Bottcher, L; Schweizer, A.; Green, J. R.; Seltenmeyer, Y.; Muller, K. Agents Actions 1989, 26, 240.
24. 15. Klein, T.; Nüsing, R. M.; Wiesenberg-Boettcher, L; Ullrich, V. Biochem. Pharmacol. 1996, 51, 285.
25. 16. Patani, G. A. & LaVoie, E. J. Chem. Rev. 1996, 96, 3147.
26. a Ed., Longman Scientific and Techinal Ed.: New York, 1991; pp 540-541.
27. 18. Gribble, G. W.; Leese, R. M. Synthesis 1976, 172.
28. 13CNMR, IR, MS) data and CHN analysis.
29. 20. Ferreira, S. H. J. Pharm. Pharmacol. 1979, 31, 648.
30. 21. Otterness, I. G.; Bliven, M. L. In Non-Steroidal Antiinflammatory Drugs; Lombardino, J. G. Ed.; Willey: New York; 1985, p 110.
31. 22. (a) Harada, Y.; Hatanaka, K.; Kawamura, M.; Saito, M.; Ogino, M.; Majima, M.; Takashi, O.; Ogino, K.; Yamamoto, K.; Taketani, Y.; Yamamoto, S.; Katori, M. Prostaglandins 1996, 51, 19.
32. (b) Tomlinson, A.; Appleton, L; Moore, A. R.; Gilroy, D. W.; Willis, D.; Mitchell, J. A.; Willoughby, D. A. Br. J. Pharmacol. 1994, 113, 693.